Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Emerging Tests-dtet
ClearNote Health Launches Early Detection Test for Pancreatic Cancer
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis
The skin-based test can be used on children as young as two days old
Lab Directors Should Follow cfDNA Testing Progress in Ongoing Study
AMP Annual Meeting attendees showed strong interest in the blood test
Diagnostics Pipeline: SimplyTest, Becton Dickinson Expand HPV Testing Capabilities
SimplyTest’s saliva-based HPV tests will be marketed to dentists and functional medicine practices
Quest Says It Will Release a More Powerful Alzheimer’s Test in 2026
The assay detects the presence of three different proteins and is slightly more accurate than a test Quest released earlier this year
New Tests Could Make Detecting Lyme Disease Speedier and More Accurate
Current assays often miss diagnoses in the early stages of the disease, delaying treatment
Diagnostic Pipeline: Labcorp Uses Chewing Gum Samples to Identify Bone Marrow Donors
The initiative is in conjunction with The Gift of Life registry and Doublemint Gum
National Lab Companies Move Quickly to Market Fujirebio’s Lumipulse for Earlier Alzheimer’s Detection
The new blood-based assay avoids painful lumbar punctures and may quicken Alzheimer’s diagnoses
Diagnostics Pipeline: Postpartum Lab Panel Launched by Trellis Health
The intent of the at-home testing is to identify and treat issues such as postpartum depression and vitamin deficiencies
Breath Biopsy Aims to Detect Lung Infections Early
A novel breath test that could transform Pseudomonas aeruginosa detection in cystic fibrosis patients
Future of Biomarkers in Multiple Sclerosis Care
MS expert Stephanie Buxhoeveden combines personal experience with scientific expertise to explore how biomarkers are transforming MS care
